Purinergic signalling in the musculoskeletal system
- 14 August 2013
- journal article
- review article
- Published by Springer Nature in Purinergic Signalling
- Vol. 9 (4) , 541-572
Abstract
It is now widely recognised that extracellular nucleotides, signalling via purinergic receptors, participate in numerous biological processes in most tissues. It has become evident that extracellular nucleotides have significant regulatory effects in the musculoskeletal system. In early development, ATP released from motor nerves along with acetylcholine acts as a cotransmitter in neuromuscular transmission; in mature animals, ATP functions as a neuromodulator. Purinergic receptors expressed by skeletal muscle and satellite cells play important pathophysiological roles in their development or repair. In many cell types, expression of purinergic receptors is often dependent on differentiation. For example, sequential expression of P2X5, P2Y1 and P2X2 receptors occurs during muscle regeneration in the mdx model of muscular dystrophy. In bone and cartilage cells, the functional effects of purinergic signalling appear to be largely negative. ATP stimulates the formation and activation of osteoclasts, the bone-destroying cells. Another role appears to be as a potent local inhibitor of mineralisation. In osteoblasts, the bone-forming cells, ATP acts via P2 receptors to limit bone mineralisation by inhibiting alkaline phosphatase expression and activity. Extracellular ATP additionally exerts significant effects on mineralisation via its hydrolysis product, pyrophosphate. Evidence now suggests that purinergic signalling is potentially important in several bone and joint disorders including osteoporosis, rheumatoid arthritis and cancers. Strategies for future musculoskeletal therapies might involve modulation of purinergic receptor function or of the ecto-nucleotidases responsible for ATP breakdown or ATP transport inhibitors.Keywords
This publication has 446 references indexed in Scilit:
- Dynamic redistribution of paxillin in bovine osteoblasts stimulated with adenosine 5′-triphosphateJournal of Molecular Histology, 2012
- Long‐term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosusArthritis Care & Research, 2012
- CD73‐generated adenosine promotes osteoblast differentiationJournal of Cellular Physiology, 2011
- Adenosine A1 receptors regulate bone resorption in mice: Adenosine A1 receptor blockade or deletion increases bone density and prevents ovariectomy‐induced bone loss in adenosine A1 receptor–knockout miceArthritis & Rheumatism, 2010
- High-frequency fatigue of skeletal muscle: role of extracellular Ca2+European Journal of Applied Physiology, 2008
- APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in miceJournal of Cellular Biochemistry, 2008
- Oscillating fluid flow activation of gap junction hemichannels induces atp release from MLO‐Y4 osteocytesJournal of Cellular Physiology, 2007
- P2 nucleotide receptors on C2C12 satellite cellsPurinergic Signalling, 2005
- Mediation of spontaneous knee osteoarthritis by progressive chondrocyte ATP depletion in Hartley guinea pigsArthritis & Rheumatism, 2004
- ATP modulates load‐inducible IL‐1β, COX 2, and MMP‐3 gene expression in human tendon cellsJournal of Cellular Biochemistry, 2003